showed a trendp < 0.05
In particular, the μg/kg contents of nerol and geraniol showed a trend increase at 35% WL ( p < 0.05 for nerol; p > 0.05 for geraniol) and then a reduction at 65% WL.
In particular, the μg/kg contents of nerol and geraniol showed a trend increase at 35% WL ( p < 0.05 for nerol; p > 0.05 for geraniol) and then a reduction at 65% WL.
Of the 12 correlation analyses performed, 3 were nominally significant ( p < 0.05) and another 2 showed a trend ( p < 0.1).
An evaluation of the Belgian adaptation showed a trend towards a decrease in overweight ( p = .05), and overweight + obesity ( p = .06) in pilot towns compared to the general population [ 16 ].
Higher thyrotropin showed a trend toward increased risk of cardiovascular mortality in younger (<72 years) participants (1.31, 1.00–1.72; P = 0.05), whereas an opposite trend was observed in elderly (≥72 years) (0.77, 0.56–1.06; P = 0.11) (Table 3 and Fig. 2a, b ).
In parents, unchanged levels of the three proteins were observed, with the exception of MAPK1/3, which showed a trend of hypo-phosphorylation ( t -test, n = 2, p -value < 0.05) in mother 53. 3.
Although differences among the two strains just showed a trend ( p < 0.05), the treatment with the PB2OPT strain produced the highest gas volume both at 24 (+9.36% and +1.67% with respect to the control and the WT strain, respectively) and 48 h of incubation (+11.9% and +1.86% with respect to the control and the WT strain, respectively).
Association with cognitive function: Higher NT-proBNP levels were associated with significantly lower DSST scores (β = −0.12; 95% CI = −0.21, −0.03; Table 4 , Model 2) and showed a trend of association with worst Stroop scores ( p = 0.05 and 0.01 in Model 1 and 2, respectively).
This area in the affected eye in DRS Type I showed a trend toward being less than that in the nonaffected eye (31.44 ± 1.21 mm 2 vs 37.32 ± 2.73 mm 2 P < 0.05).
With the addition of CSN, the WS value of the pH-responsive film showed a trend of decreasing ( p < 0.05).
The levodopa-equivalent daily dosage showed a trend towards a negatively moderating effect on antisaccade error rate with a statistical significance at the cut-off value ( p =0.05).
In anterior lumbar roots ( Figures 3 C, 3D, 3G, and 3H), the ratio of abnormally myelinated fibers reached 0.25 ± 0.01 (n = 11) in mock compared to 0.15 ± 0.02 in treated mice (n = 11; p = 0.0002; Figure 3 K), while the numbers of foamy macrophages showed a trend for decrease in treated (9.18 ± 1.66; n = 11) compared to the mock-treated mice (13.35 ± 1.21; n = 11; p > 0.05; Figure 3 L).
Mean body weight showed a trend of increasing and then decreasing from Q1 to Q4 and was highest in group Q3 (P<0.05).
Consistent with our previous results, iPSC-derived SNs with WT FUS showed a trend toward decreased tracing over time, which did not reach statistical significance ( Supplementary Figures S2C,D ). iPSC-derived SNs with P525L FUS-eGFP showed a 5-fold decrease in tracing ( p < 0.05, 2way ANOVA, Sidak post-test for multiple comparisons; Supplementary Figures S2C,D ), consistent with the age-dependent neurodegeneration observed in ALS.
In Met, LoDG and MetDG compared to CTRL, hexose showed a trend towards lower levels ( p > 0.05, Fig. 5 ).
Regarding the main effect of intervention, the PBM group showed a trend toward increased Pomc mRNA expression compared with the control group ( p = 0.05).
Walking time showed a trend toward greater calf swelling (B = 0.073, P = 0.050), while standing time showed a trend toward less calf swelling (B = − 0.074, P = 0.059).
17 Bryne et al demonstrated that six cycles of cyclophosphamide, vincristine, and methotrexate (CVM) consolidation after induction therapy showed a trend toward inferior OS (median OS: 14.1 months vs 19.2 months, P =0.05). 18 In addition to the four studies previously mentioned, other studies also explored the role of CCT in SCLC; however, those studies randomized both limited and extensive stages and came to different conclusions.
Comparison of the number of intracellular ATP molecules in 2-, 6-, 12-, and 18-month-old neurons showed a trend of increase with age, which was signed between the 2- and 12-month neurons ( Figure 5 A; p < 0.05).
Likewise, peer bonding as a motivator for engaging in NSSI, as measured by the ISAS, showed a trend toward negatively correlating with EMG activity of the corrugator muscle in response to viewing angry facial expressions (r = -0.361, p = 0.05).
Sniffing duration of the VPA-exposed mice in the empty wire cage showed a trend that was slightly higher than the control and the KRG treated groups ( p >0.05).
While rhPRG4 treatment showed a trend towards a reduction in PL IL-1β at 24h in Prg4 GT/GT animals, this trend was not statistically significant ( p>0.05 ), due to a high degree of variability in calculated IL-1β concentrations in specimens from the same experimental group.
While worker bees in fermented pollen group showed a trend towards increased body weight compared to unfermented control group, this difference was not statistically significant ( P > 0.05).
As expected, the Schmidt’s score was markedly increased in both AP models, and in Cer-AP it was reduced in mice treated with APOA1 and FGF21 LNP-mRNAs, whereas in the EtOH/POA-AP model APOA1 LNP-mRNA significantly reduced this score, and FGF21 and APOA1-FGF21 LNP-mRNAs showed a trend toward a therapeutic effect ( p -value = 0.05) (Figs. 5 B and 6 B).
This is supported by a sub-analysis in KMT2A -rearranged patients, where TRM was similar in both groups, and OS showed a trend towards improvement (63% vs 53%, p=0.05). 11 Despite the lack of benefit in terms of OS in the total cohort, the results of this trial ultimately led to FDA approval for de novo AML patients aged ≥1 month.
Apremilast showed a trend to increase IL-6 in this murine cell line (from 811 ± 416 to 1,986 ± 881 pg/ml, P <0.05) and modestly diminished the LPS-mediated increase of IL-1α (from 149 ± 26 to 97 ± 35 pg/ml, P <0.05).